The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1605
August 24, 2020
View Complete Issue         Table of Contents 2019 
Phexxi - A Nonhormonal Contraceptive Gel
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Phexxi - A Nonhormonal Contraceptive Gel
August 24, 2020 (Issue: 1605)
The FDA has approved Phexxi (Evofem), a nonhormonal prescription-only vaginal gel containing lactic acid, citric acid, and potassium bitartrate, for prevention of pregnancy. The gel is intended for on-demand contraception; it is not effective...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Phexxi - A Nonhormonal Contraceptive Gel
Article code: 1605a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.